Andersen, Morten Nørgaard http://orcid.org/0000-0003-0820-7789
Etzerodt, Anders
Graversen, Jonas H.
Holthof, Lisa C.
Moestrup, Søren K.
Hokland, Marianne
Møller, Holger J.
Article History
Received: 30 August 2018
Accepted: 6 January 2019
First Online: 14 January 2019
Compliance with ethical standards
:
: Jonas H. Graversen, Søren K. Moestrup, and Holger J. Møller are minority shareholders in Affinicon ApS, which holds IP protecting the use of CD163 drug targeting. The other authors declare no conflict of interest.
: Buffy coats (residual product from blood processing) were collected anonymously from volunteer donors during routine blood donation at the blood bank, Department of Clinical Immunology, Aarhus University Hospital, Denmark (project number 0094). Volunteers gave informed written consent before blood donation. According to Danish law, this use of anonymized buffy coats does not require separate ethical approval.